89 results on '"Nöllke P"'
Search Results
2. IDENTIFICATION OF HIGH-RISK JMML BY BMP4 BISULFITE NEXT-GENERATION SEQUENCING
3. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia
4. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
5. P051 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: THE EVOLVING GENETIC LANDSCAPE OF PEDIATRIC MDS-EB
6. O19 - GENETIC ORIGINS AND CLONAL TRAJECTORIES IN PEDIATRIC MYELODYSPLASTIC SYNDROMES
7. P47 - Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes: HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH GATA2-RELATED MYELODYSPLASTIC SYNDROME
8. O27 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: OUTCOMES OF RELAPSED JUVENILE MYELOMONOCYTIC LEUKEMIA: THE ROLE OF SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION
9. O05 - Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: SOMATIC GENETIC RESCUE IN SAMD9/SAMD9L MDS PREDISPOSITION SYNDROMES
10. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood
11. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study
12. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia
13. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia
14. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)
15. Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia
16. Immunosuppressive therapy with anti-thymocyte globin and cyclosporine A in patients with refractory cytopenia in childhood: P1166
17. Allogenic stem cell transplantation for children with advanced MDS: results from the EWOG-MDS study group employing a pre-transplant preparative regimen with busulfan, cyclophosphamide and melphalan
18. Machine learning algorithms for the automated classification of pediatric anemia
19. Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia
20. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial
21. Novel non-synonymous coding MPL-gene variants in two unrelated infants with congenital amegakaryocytic thrombocytopenia
22. Genome-Wide DNA Methylation Profiling Reveals Distinct Molecular Subgroups of Juvenile Myelomonocytic Leukemia with Clinical Significance
23. Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas
24. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood
25. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia
26. Aberrant DNA Methylation Caracterizes a Subtype of Juvenile Myelomonocytic Leukemia (JMML) wit Poor Outcome
27. 34 - Genome-Wide DNA Methylation Profiling Reveals Distinct Molecular Subgroups of Juvenile Myelomonocytic Leukemia with Clinical Significance
28. Refractory anemia in childhood:A retrospective analysis of 67 cases with particular reference to monosomy 7
29. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome
30. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia
31. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
32. 146. Preceding repetitive stimulation diminishes long-term potentiation-like plasticity in human motor cortex
33. Preceding repetitive stimulation diminishes long-term potentiation-like plasticity in human motor cortex
34. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia
35. RASA4undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia
36. 378 Morphological differentiation of hypocellular refractory cytopenia of childhood and severe aplastic anemia and clinical outcome
37. 2 Morphological differentiation of hypocellular refractory cytopenia of childhood and severe aplastic anemia and clinical outcome
38. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome
39. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial
40. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7
41. C029 Hematopoietic stem cell transplantation for advanced primary MDS in children: results of a retrospective analysis from the EWOG-MDS group
42. C030 Hematopoietic stem cell transplantation after a myeloablative conditioning regimen in children with refractory cytopenia: results of a retrospective analysis from the EWOG-MDS group
43. Characteristics and outcome of treatment-related MDS after childhood cancer: The EWOG-MDS experience
44. Treatment of JMML other than stem cell transplantation: A retrospective analysis of 129 treatment courses in 63 patients
45. Aberrant DNA Methylation Characterizes a Subtype of Juvenile Myelomonocytic Leukemia (JMML) with Poor Outcome.
46. Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups.
47. High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials.
48. Next-generation reference intervals for pediatric hematology.
49. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
50. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.